NCT00398333View on ClinicalTrials.gov

Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Colorectal Neoplasms
Interventions
DIETARY_SUPPLEMENT

Eicosapentaenoic acid enriched nutritional supplement

Oral intake of nutritional supplementation: a maximum of 480 mL or a minimum of 240 mL daily during the first 3 months of the study.

Trial Locations (1)

08036

Hospital Clinic of Barcelona, Barcelona

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Hospital Clinic of Barcelona

OTHER